By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Ophthalmic steroids > Dexycu (intraocular) > Dexycu Dosage
Ophthalmic steroids
https://themeditary.com/dosage-information/dexycu-dosage-2308.html

Dexycu Dosage

Drug Detail:Dexycu (intraocular) (Dexamethasone (intraocular) [ dex-a-meth-a-sone ])

Generic Name: DEXAMETHASONE 517ug in 0.005mL

Dosage Form: injection, suspension

Drug Class: Ophthalmic steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Dosing Information

DEXYCU should be administered as a single dose, intraocularly in the posterior chamber at the end of surgery. The dose is 0.005 mL of dexamethasone 9% (equivalent to 517 micrograms).

Preparation and Administration

Each kit of DEXYCU is for a single administration. After preparation, 0.005 mL will be administered.

The DEXYCU administration kit contains the following items:

Figure

  1. One glass vial: 0.5 mL of DEXYCU
  2. One sterile 1-mL syringe
  3. One sterile syringe guide
  4. One sterile syringe ring
  5. One sterile 18-gauge needle (1½ inches long), plastic cap attached
  6. One sterile 25-gauge bent cannula (8 mm long), plastic cap attached
Step 1.
Prepare a sterile field.
Remove the components of the administration kit from their respective pouches:
  • syringe
  • syringe guide
  • syringe ring
  • needle
  • cannula
Place onto the sterile field.
Figure
Step 2.
Withdraw the syringe plunger approximately 1 inch.
Place the syringe ring on the plunger (slit facing the plunger).
Apply slight downward pressure until the syringe ring "snaps" into place.
Figure
Step 3.
Place the 18-gauge needle firmly on the syringe.
Remove the cap from the needle.
Depress the plunger completely and then withdraw the plunger to fill the syringe with air.
Figure
Step 4.
​Mix using a vortex mixer or vigorously shake the vial of DEXYCU sideways for a minimum of 30 seconds.
The suspended drug material must be used immediately after shaking.
Figure
Step 5.
Remove the blue plastic flip-cap from the vial and wipe the top of rubber stopper with an alcohol pad.
Invert the vial.
Figure
Step 6.
Insert the needle into the vial and inject the air into the vial.
Making sure the needle tip is immersed in the drug material pooled in the neck of the inverted vial, fill the syringe by slowly withdrawing the plunger approximately 0.2 mL.
Remove the needle from the vial and discard the unused portion in the vial.
Figure
Step 7.
Remove the needle from the syringe.
Firmly place the cannula on the syringe and remove the plastic cap.
Hold the syringe vertically with the cannula pointing up.
Depress the plunger to expel air bubbles from syringe.
Figure
Step 8.
Affix the syringe guide over the syringe ring on the plunger.
Figure
Step 9.
Depress the plunger until the syringe guide/ring mechanism comes gently into contact with the flange of the syringe.
Lightly tap/flick the barrel of the syringe to remove any excess drug from the tip of the cannula.
Do not wipe or touch the tip of the cannula to remove excess drug.
Figure
Step 10.
Remove the syringe guide, leaving the syringe ring in place.
Caution to not move the plunger. The space between the syringe ring and the top of the plunger is the medication injection volume that will be applied to the patient's eye.
The syringe is now ready for injection.
Figure
Step 11.
In a single slow motion, inject 0.005 mL of the drug material behind the iris in the inferior portion of the posterior chamber. If the sphere of administered drug after intraocular injection appears to be larger than 2 mm in diameter, excess drug material may be removed by irrigation and aspiration in the sterile surgical setting
PLEASE NOTE: Some drug material will remain in the syringe after the injection—this is necessary for accurate dosing. Discard unused portion remaining in the syringe after administration.
Figure
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by